for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Amicus Announces Additional Data In Pompe Disease Phase 1/2 Study

Feb 7 (Reuters) - Amicus Therapeutics Inc:

* AMICUS THERAPEUTICS ANNOUNCES ADDITIONAL POSITIVE DATA IN POMPE DISEASE PHASE 1/2 STUDY AT 14TH ANNUAL WORLDSYMPOSIUM™

* AMICUS THERAPEUTICS INC - CONSISTENT AND DURABLE RESPONSES ACROSS KEY MEASURES OF SAFETY, FUNCTIONAL OUTCOMES AND BIOMARKERS OUT TO MONTH 12 IN TRIAL

* AMICUS THERAPEUTICS INC - VERY LOW RATE (<1%) OF INFUSION ASSOCIATED REACTIONS MAINTAINED AFTER 550+ INFUSIONS IN TRIAL Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up